Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

IBA and Philips Announce First Installation of Patient-Centered Proton Treatment Room



  IBA and Philips Announce First Installation of Patient-Centered Proton
  Treatment Room

2012 ASTRO Annual Meeting Booth #3019

Business Wire

BOSTON -- October 28, 2012

IBA Group, a leader in advanced cancer diagnosis and therapy technologies, and
Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced their
first-ever installation of a state-of-the-art, patient-centered proton therapy
treatment room in the United States. A new addition to the Willis-Knighton
Cancer Center in Shreveport, La., will be the first IBA installation to
incorporate the Philips Ambient Experience.

Together with Philips Healthcare, IBA is demonstrating a life-size model of
the Proteus(R)ONE proton ...

Together with Philips Healthcare, IBA is demonstrating a life-size model of
the Proteus(R)ONE proton therapy room combined with the Philips Ambient
Experience solution in booth #3019 at the 54th annual meeting of ASTRO, the
American Society for Radiation Oncology, in Boston. (Photo: IBA)

Designed and engineered by Philips Healthcare, the Philips Ambient Experience
promotes patient relaxation during proton treatments by permitting patients to
selectively add comforting light, sound and images to the treatment room
environment before they begin therapy. This will help improve the patient and
staff experience, turning a cold, impersonal environment into one that
comforts and reassures as the patient becomes an active participant in the
process.

“This new installation is the first to come to fruition from the Philips-IBA
cooperative agreement,” said Olivier Legrain, Chief Executive Officer at IBA.
“It is demonstrative of a successful collaboration with Philips in offering
highly advanced, patient-centered care, and we are delighted it will be
integrated into our new proton system installations.”

“Ambient Experience enhances our ability to provide superior cancer care,”
said Dr. Lane Rosen of the Willis-Knighton Cancer Center. “The soothing and
empowering atmosphere will make our patients more comfortable, which will
allow our staff to work more efficiently. IBA and Philips have been excellent
partners, so it made sense to work with them to bring this unique experience
to our patients.”

Willis-Knighton will be the first center to utilize Proteus^®ONE*, IBA’s
single-room compact gantry solution for those looking for a more
cost-effective, smaller footprint option. The $40 million project is expected
to begin treating cancer patients with protons in early 2014.

Together with Philips, IBA is demonstrating a life-size model of the
ProteusONE proton therapy room combined with the Philips Ambient Experience
solution in booth #3019 at the 54^th annual meeting of ASTRO, the American
Society for Radiation Oncology, in Boston.

*Proteus^®ONE is the brand name of a new configuration of the Proteus^®235,
including some new developments subject to review by Competent Authorities
(FDA, European Notified Bodies, et al.) before marketing.

About IBA
IBA (Ion Beam Applications S.A.) is a cancer diagnostics and treatment company
and the worldwide technology leader in the field of proton therapy. The
company’s expertise lies in the development of next-generation proton therapy
technologies and radiopharmaceuticals that provide oncology care providers
with premium quality services and equipment, including IBA’s leading fully
integrated IntegraLab^® radiopharmacy system, and Dosimetry advanced solutions
for Quality Assurance of medical equipment and increased patient safety.

Headquartered in Belgium and employing more than 1,200 people worldwide, IBA
currently has installed systems across Europe and the U.S. and is expanding
into emerging markets. The company is focused on building sustainable global
growth for investors, providing solutions in the fight against cancer.
IBA is listed on the pan-European stock exchange EURONEXT.
Website: www.iba-worldwide.com

About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and
well-being company, focused on improving people’s lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6
billion and employs approximately 121,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care, acute care
and home healthcare, energy efficient lighting solutions and new lighting
applications, as well as male shaving and grooming, home and portable
entertainment and oral healthcare.
News from Philips is located at www.philips.com/newscenter.

About Willis-Knighton Cancer Center
Opened in 2000, the Willis-Knighton Cancer Center provides a wide range of
treatment options for cancer patients, including radiation oncology, medical
oncology and hematology, surgical oncology, and gynecologic oncology. A
regional comprehensive cancer center, Willis-Knighton provides diagnostic
services such as PET/CT, X-ray, CT and laboratory. It also offers social
services counseling, nutritional counseling, educational resources, community
education programs and support groups.
Website: www.wkhs.com/Cancer

Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50456435&lang=en

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50456435&lang=en

Contact:

IBA
William Hansen
Global Marketing Director
p. +1 612 804 5559
e. william.hansen@iba-group.com
or
For media and investor enquiries about IBA:
M:Communications
Mary-Jane Elliott, Amber Bielecka, Claire Dickinson
p. +44 (0) 207 920 2333
e. IBA@mcomgroup.com
or
Philips
Stefan Martens
Marketing Director Ambient Experience
p. + 31 6 2088 1704
e. Stefan.Martens@philips.com
or
Philips Healthcare Communications
Sabine van Deursen
p. +31 (0)615043894
e. sabine.van.deursen@philips.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement